Is severe depression a separate indication?1Chair: SA Montgomery, Y. Lecrubier.Participants: E. Abadie, M. Ackenheil, J. Angst, P. Bech, P. Bouka, M. Briley, S. Eisen, J.-D. Guelfi, S. Kasper, J. Keogeorgos, B. Picon, R.M. Pinder, A. Puech, A. Sitzen, C.R. Soldatos, J.M. Van Ree, B.J. Van Zwieten-Boot.Rapporteur: D.B. Montgomery.1
- 8 March 1999
- journal article
- review article
- Published by Elsevier in European Neuropsychopharmacology
- Vol. 9 (3) , 259-264
- https://doi.org/10.1016/s0924-977x(98)00048-0
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Milnacipran and selective serotonin reuptake inhibitors in major depressionInternational Clinical Psychopharmacology, 1996
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressantsJournal of Psychopharmacology, 1994
- Moclobemide: a reversible MAO-A-inhibitor showing weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1993
- A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patientsThe British Journal of Psychiatry, 1991
- Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter studyJournal of Affective Disorders, 1990
- Nortriptyline in depressed patients with high plasma levels. IIClinical Pharmacology & Therapeutics, 1978
- Prediction of Tricyclic Antidepressant ResponseArchives of General Psychiatry, 1976
- Self-inhibiting action of nortriptylin's antidepressive effect at high plasma levelsPsychopharmacology, 1976
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960